Company Filing History:
Years Active: 2025
Title: Jennifer Thom: Innovator in Antigen Binding Molecules
Introduction
Jennifer Thom is a prominent inventor based in Craigavon, GB. She has made significant contributions to the field of biotechnology, particularly in the development of antigen binding molecules.
Latest Patents
Jennifer holds a patent for ROR1-specific antigen binding molecules. This invention relates to receptor tyrosine kinase-like orphan receptor 1 (ROR1) specific antigen binding molecules and associated fusion proteins and conjugates. Additionally, her work includes conjugated immunoglobulin-like shark variable novel antigen receptors (VNARs).
Career Highlights
Jennifer is currently employed at Almac Discovery Limited, where she continues to advance her research and innovation in the field. Her work has garnered attention for its potential applications in therapeutic development.
Collaborations
Jennifer collaborates with esteemed colleagues, including Estelle Grace McLean and Paul Richard Trumper, who contribute to her research endeavors.
Conclusion
Jennifer Thom is a trailblazer in the field of antigen binding molecules, with her innovative work paving the way for future advancements in biotechnology.